ANP - Antisense Therapeutics Ltd (ASX) Stock Forum
ASX:ANP is an Australian biopharmaceutical company that specializes in developing and commercializing antisense pharmaceuticals for the treatment of rare diseases. The company's lead product candidate, ATL1102, is currently in clinical trials for the treatment of Duchenne muscular dystrophy and multiple sclerosis. As an Aussie stock, ANP may be of interest to traders on our forum who are looking for opportunities in the biotech sector.
